CD40 ligand
| GO Term | Evidence Code | Reference |
|---|---|---|
| regulation of immunoglobulin production | ||
| positive regulation of immune response to tumor cell | ||
| inflammatory response | ||
| inflammatory response | ||
| cell surface receptor signaling pathway |
| GO Term | Evidence Code | Reference |
|---|---|---|
| obsolete extracellular space |
|
|
| Golgi apparatus |
|
|
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| cytokine activity | ||
| cytokine activity | ||
| tumor necrosis factor receptor binding | ||
| CD40 receptor binding | ||
| CD40 receptor binding |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 239 |
|
|
| Pathway Name | Organism |
|---|---|
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | Rattus norvegicus |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | Rattus norvegicus |
| TNFR2 non-canonical NF-kB pathway | Rattus norvegicus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060903 | thrombosis | |
| DOID:0050731 | vitamin B12 deficiency | |
| DOID:4780 | anti-basement membrane glomerulonephritis | |
| DOID:10591 | pre-eclampsia | |
| DOID:5050 | Ehrlich tumor carcinoma | |
| DOID:9744 | type 1 diabetes mellitus | |
| DOID:1936 | atherosclerosis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026